Company Analysis
Sign in

Surrozen, Inc. (SRZN)

Nasdaq: SRZN · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2020
Full chart Alerts Compare
Grade2.7
◀ Past 1.9● Present 2.5▶ Future 3.4
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedMar 23, 2026Mar 31, 2025Apr 10, 2024Mar 31, 2023Mar 28, 2022Mar 31, 2021
Revenue3,477,00010,655,000012,500,0000·
Research and development29,365,00021,132,00027,230,00037,013,00040,177,00025,684,000
General and administrative16,204,00015,062,00015,798,00019,826,00014,214,0007,123,000
Total operating expenses45,569,00036,194,00045,780,00056,839,00054,391,00032,807,000
Operating income-42,092,000-25,539,000-45,780,000-44,339,000-54,391,000-32,807,000
Interest and investment income3,020,0001,693,0002,340,000781,00072,00091,000
Other income (expense), net-26,312,000-19,321,000398,0007,554,000-329,0000
Income before income taxes-242,028,000-63,563,000····
Income tax expense000000
Net income including non-controlling interests-242,026,000-63,564,000-43,042,000-36,004,000-54,648,000-32,716,000
Net income-242,026,000-63,564,000-43,042,000-36,004,000-54,648,000-32,716,000
Earnings per share, basic-32.37-21.67-21.33-15.56r-33.15b·
Earnings per share, diluted-32.37-21.67-21.33-15.56r-33.15b·
Weighted average shares, basic7,4782,9332,0182,314r1,646b·
Weighted average shares, diluted7,478,000b2,933,000b2,018,000b2,314,000rb1,646,000b·
Weighted average shares, basic and diluted····1,645,956b1,064,823b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton SRZN · research, not advice